US 12084438
GCN2 inhibitors and uses thereof
granted A61PA61P35/00
Quick answer
US patent 12084438 (GCN2 inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61P, A61P35/00